LumaCyte Revenue and Competitors

Location

#8654

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • LumaCyte's estimated annual revenue is currently $5.1M per year.(i)
  • LumaCyte's estimated revenue per employee is $155,000

Employee Data

  • LumaCyte has 33 Employees.(i)
  • LumaCyte grew their employee count by 43% last year.

LumaCyte's People

NameTitleEmail/Phone
1
CEO & Chief Scientific OfficerReveal Email/Phone
2
President & Chief Business OfficerReveal Email/Phone
3
SVP, Scientific and Business OperationsReveal Email/Phone
4
Director, Customer OperationsReveal Email/Phone
5
Director Manufacturing and ServiceReveal Email/Phone
6
Director Software EngineeringReveal Email/Phone
7
Director, Instrumentation R&D / EngineeringReveal Email/Phone
8
Director Application SciencesReveal Email/Phone
9
Executive Director, Business Development – EuropeReveal Email/Phone
10
Financial ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.4M9-10%N/AN/A
#2
$4.3M284%N/AN/A
#3
$1.1M70%N/AN/A
#4
$3.5M45-52%$56.5MN/A
#5
$0.3M20%N/AN/A
#6
$4.5M2921%N/AN/A
#7
$1.9M129%N/AN/A
#8
$7M455%N/AN/A
#9
$6.7M435%N/AN/A
#10
$2M13-13%N/AN/A
Add Company

What Is LumaCyte?

LumaCyte is an advanced research and bioanalytics instrumentation company that produces label-free, single cell analysis and sorting instrumentation where the use of antibody or genetic labeling is not required for cellular analysis. This revolutionary technology utilizes Laser Force Cytologyâ„¢ (LFCâ„¢) to measure optical and fluidic forces within a microfluidic channel to identify and measure the intrinsic cellular properties of each cell. The multivariate nature of the data has enabled a host of Big Data strategies and cloud computing capabilities that drive advanced analytics, allowing a deeper understanding of cell based biological systems. Applications of LumaCyte's label-free platform technology include viral infectivity for vaccine development and manufacturing, cell and gene therapy development and production monitoring, cancer biology R&D, CAR T-cell immunotherapy, iPSCs, infectious disease, and pre-clinical drug discovery, in addition to multiple applications across the biomanufacturing sector for quality control and process optimization. Innovate. Discover. Transform.

keywords:N/A

N/A

Total Funding

33

Number of Employees

$5.1M

Revenue (est)

43%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.5M33-13%N/A
#2
$2.6M336%N/A
#3
N/A333%N/A
#4
N/A3350%N/A
#5
$2.6M33-6%N/A